Scholar Rock Holding Corp - Common Stock (SRRK)
CUSIP: 80706P103
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 102,846,929
- Total 13F shares
- 88,604,135
- Share change
- -8,613,927
- Total reported value
- $710,205,939
- Put/Call ratio
- 130%
- Price per share
- $8.01
- Number of holders
- 160
- Value change
- -$73,277,440
- Number of buys
- 76
- Number of sells
- 82
Quarterly Holders Quick Answers
What is CUSIP 80706P103?
CUSIP 80706P103 identifies SRRK - Scholar Rock Holding Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 80706P103:
Top shareholders of SRRK - Scholar Rock Holding Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Samsara BioCapital GP, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
6,788,609
|
$108,133,716 | — | 16 Oct 2023 | |
| Siren, L.L.C. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
11,259,438
|
$101,166,050 | — | 25 Jul 2024 | |
| Artal Group S.A. |
13F
|
Company |
11%
|
11,259,438
|
$93,791,119 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
9.6%
|
9,887,233
|
$82,360,651 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
8%
|
8,188,127
|
$68,208,000 | — | 30 Jun 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
6.6%
|
6,788,609
|
$56,549,113 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.5%
|
5,664,419
|
$47,184,610 | — | 30 Jun 2024 | |
| Redmile Group, LLC |
13F
|
Company |
5.3%
|
5,453,083
|
$45,424,181 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.7%
|
3,836,560
|
$31,958,544 | — | 30 Jun 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
3%
|
3,074,475
|
$25,610,377 | — | 30 Jun 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2.9%
|
2,940,672
|
$24,495,798 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
2,808,924
|
$23,398,337 | — | 30 Jun 2024 | |
| Bellevue Group AG |
13F
|
Company |
2.1%
|
2,165,203
|
$18,036,141 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
1,422,536
|
$11,851,753 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
1,339,081
|
$11,154,545 | — | 30 Jun 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1%
|
1,074,382
|
$8,949,602 | — | 30 Jun 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
1%
|
1,028,330
|
$8,565,989 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.9%
|
925,584
|
$7,710,115 | — | 30 Jun 2024 | |
| Nagesh K. Mahanthappa |
3/4/5
|
Interim CEO and President |
—
mixed-class rows
|
530,491
mixed-class rows
|
$7,653,597 | — | 16 Jun 2022 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.81%
|
832,792
|
$6,937,157 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.78%
|
800,672
|
$6,669,598 | — | 30 Jun 2024 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.73%
|
747,105
|
$6,223,388 | — | 30 Jun 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.72%
|
744,443
|
$6,200,921 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.69%
|
708,187
|
$5,899,198 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.57%
|
590,800
|
$4,921,364 | — | 30 Jun 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.57%
|
583,774
|
$4,862,837 | — | 30 Jun 2024 | |
| BIT Capital GmbH |
13F
|
Company |
0.51%
|
528,288
|
$4,400,639 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.49%
|
505,224
|
$4,208,515 | — | 30 Jun 2024 | |
| Yung H. Chyung |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
295,996
mixed-class rows
|
$4,117,505 | — | 14 Feb 2022 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.47%
|
487,285
|
$4,059,083 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.45%
|
460,654
|
$3,837,248 | — | 30 Jun 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.43%
|
439,557
|
$3,661,508 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.41%
|
425,312
|
$3,542,849 | — | 30 Jun 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.39%
|
400,000
|
$3,332,000 | — | 30 Jun 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.37%
|
381,025
|
$3,173,938 | — | 30 Jun 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
0.36%
|
372,559
|
$3,103,416 | — | 30 Jun 2024 | |
| AXA S.A. |
13F
|
Company |
0.36%
|
372,250
|
$3,100,843 | — | 30 Jun 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.36%
|
366,078
|
$3,049,430 | — | 30 Jun 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.3%
|
309,646
|
$2,579,351 | — | 30 Jun 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.27%
|
279,951
|
$2,331,992 | — | 30 Jun 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.27%
|
272,795
|
$2,272,382 | — | 30 Jun 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.26%
|
269,281
|
$2,243,111 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.25%
|
254,039
|
$2,116,144 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.25%
|
253,527
|
$2,111,880 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.24%
|
248,736
|
$2,072,070 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.24%
|
247,567
|
$2,062,234 | — | 30 Jun 2024 | |
| Gregory John Carven |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
173,708
mixed-class rows
|
$2,042,187 | — | 16 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
230,450
|
$1,919,645 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.22%
|
225,145
|
$1,875,458 | — | 30 Jun 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.22%
|
222,800
|
$1,855,924 | — | 30 Jun 2024 |
Institutional Holders of Scholar Rock Holding Corp - Common Stock (SRRK) as of Q3 2024
As of 30 Sep 2024,
Scholar Rock Holding Corp - Common Stock (SRRK) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
88,604,135 shares.
The largest 10 holders included
Siren, L.L.C., FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Samsara BioCapital, LLC, BlackRock, Inc., Redmile Group, LLC, VANGUARD GROUP INC, Polar Capital Holdings Plc, STATE STREET CORP, and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
160
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
162
Q3 2024 holders
160
Holder diff
-2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.